AmCad BioMed Corporation
4188.TWO
Price:
$15.3
Market Cap:
$968.99M
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis, and obstructive sleep apnea. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-CA, a software device for analyzing digital cytological images; AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2013-12-26
Stock Exchange
TWO
Ticker
4188.TWO
PE Ratio
[-20.13]
ROE
[-10.14%]
Current Ratio
[24.52]
Dividend Yield
[0%]
Enterprise Value
[966.32M]
Dividend History
The ROE as of December 2025 (TTM) for AmCad BioMed Corporation (4188.TWO) is -10.14%
According to AmCad BioMed Corporation’s latest financial reports and current stock price. The company's current ROE is -10.14%. This represents a change of 298.58% compared to the average of -2.54% of the last 4 quarters.
AmCad BioMed Corporation (4188.TWO) Historical ROE (quarterly & annually)
How has 4188.TWO ROE performed in the past?
The mean historical ROE of AmCad BioMed Corporation over the last ten years is -7.63%. The current -10.14% ROE has changed 32.83% with respect to the historical average. Over the past ten years (40 quarters), 4188.TWO's ROE was at its highest in in the December 2024 quarter at -1.19%. The ROE was at its lowest in in the December 2022 quarter at -4.75%.
Average
-7.63%
Median
-8.01%
Minimum
-12.60%
Maximum
0%
AmCad BioMed Corporation (4188.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of AmCad BioMed Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 138.19%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -12.60%
| Year | ROE | Change |
|---|---|---|
| 2024 | -8.89% | -25.30% |
| 2023 | -11.91% | -5.49% |
| 2022 | -12.60% | 138.19% |
| 2021 | -5.29% | -25.73% |
| 2020 | -7.12% | -Infinity% |
AmCad BioMed Corporation (4188.TWO) Average ROE
How has 4188.TWO ROE performed in the past?
The current ROE of AmCad BioMed Corporation (4188.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.13%
5-year avg
-9.16%
10-year avg
-7.63%
AmCad BioMed Corporation (4188.TWO) ROE vs. Peers
How is 4188.TWO’s ROE compared to its peers?
AmCad BioMed Corporation’s ROE is greater than PlexBio Co., Ltd. (-18.38%), greater than TFBS Bioscience Inc. (-4.90%), greater than Puriblood Medical Co., Ltd. (-4.41%), greater than SynCore Biotechnology Co.,Ltd (-18.31%), greater than NatureWise Biotech & Medicals Corporation (-5.58%), greater than Radiant Innovation Inc. (-6.54%), greater than Eusol Biotech Co.,Ltd. (-10.52%), greater than Andros Pharmaceuticals Co.,Ltd (-18.09%), greater than LAUNXP Biomedical Co., Ltd (-56.54%), greater than General Biologicals Corporation (-110.52%),
| Company | ROE | Market cap |
|---|---|---|
| -18.38% | $894.49M | |
| -4.90% | $751.21M | |
| -4.41% | $967.64M | |
| -18.31% | $905.50M | |
| -5.58% | $1.04B | |
| -6.54% | $864.28M | |
| -10.52% | $835.70M | |
| -18.09% | $1.22B | |
| -56.54% | $1.10B | |
| -110.52% | $723.91M |
Build a custom stock screener for AmCad BioMed Corporation (4188.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AmCad BioMed Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
AmCad BioMed Corporation (4188.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like AmCad BioMed Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is AmCad BioMed Corporation's ROE?
How is the ROE calculated for AmCad BioMed Corporation (4188.TWO)?
What is the highest ROE for AmCad BioMed Corporation (4188.TWO)?
What is the 3-year average ROE for AmCad BioMed Corporation (4188.TWO)?
What is the 5-year average ROE for AmCad BioMed Corporation (4188.TWO)?
How does the current ROE for AmCad BioMed Corporation (4188.TWO) compare to its historical average?